41 – 50 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Genetically targeted clinical trials in parkinson’s disease : Learning from the successes made in oncology
(
- Contribution to journal › Scientific review
-
Mark
Nrf2 activation and downstream effects : Focus on parkinson’s disease and brain angiotensin
(
- Contribution to journal › Scientific review
-
Mark
High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease
(
- Contribution to journal › Article
-
Mark
Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions
(
- Contribution to journal › Article
- 2020
-
Mark
Parkinson’s disease laterality : a 11C-PE2I PET imaging study
2020) In Journal of Neurology(
- Contribution to journal › Article
-
Mark
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients : an European multicentre survey
(
- Contribution to journal › Article
-
Mark
The Orthostatic Hypotension Questionnaire in Swedish tested in patients with parkinsonism
(
- Contribution to journal › Article
-
Mark
Exploring the Effects of Deep Brain Stimulation and Vision on Tremor in Parkinson's Disease : Benefits from Objective Methods
(
- Contribution to journal › Article
-
Mark
Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson’s Disease Model
(
- Contribution to journal › Article
-
Mark
The properties of α-synuclein secondary nuclei are dominated by the solution conditions rather than the seed fibril strain
(
- Contribution to journal › Article